| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII |
|
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C11H17N |
| Molar mass | 163.264 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| |
| |
| | |
Xylopropamine (Perhedrin,Esanin), also known as3,4-dimethylamphetamine, is astimulantdrug of thephenethylamine andamphetamine classes which was developed and marketed as anappetite suppressant in the 1950s.[1]
Xylopropamine was briefly sold as thesulfatesalt, but it was not widely marketed. Other related amphetamine derivatives such as2,4-dimethylamphetamine were also investigated for the same purpose, however these drugs had negative side effects such as high blood pressure and were not very successful, mainly due to the introduction of alternative drugs likephentermine which had similar efficacy but fewer side effects.
Xylopropamine was also reported as havinganalgesic[2] andanti-inflammatory[3] effects but its side effect profile resulted in it never being further developed for these applications.